UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hemodynamic outcomes after valve-in-valve transcatheter aortic valve replacement: a single-center experience

Annals of cardiothoracic surgery, 2021-09, Vol.10 (5), p.630-640

2021

Volltextzugriff (PDF)

The cancer patient and cardiology

European journal of heart failure, 2020-12, Vol.22 (12), p.2290-2309

2020

Volltextzugriff (PDF)

Patient Characteristics and Outcomes of Type 2 Myocardial Infarction During Heart Failure Hospitalizations in the United States

The American journal of medicine, 2021-11, Vol.134 (11), p.1371-1379.e2

2021

Volltextzugriff (PDF)

Contemporary impacts of a cancer diagnosis on survival following in-hospital cardiac arrest

Resuscitation, 2019-09, Vol.142, p.30-37

2019

Volltextzugriff (PDF)

Associations between global longitudinal strain (GLS), N-terminal-prohormone brain natriuretic peptide (NT-proBNP) and subsequent cardiomyopathy (CM) in a clinically assessed cohort of childhood cancer survivors exposed to cardiotoxic therapy

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.10052-10052

2022

Volltextzugriff (PDF)

Transcatheter aortic valve replacement after chest radiation: A propensity-matched analysis

International journal of cardiology, 2021-04, Vol.329, p.50-55

2021

Volltextzugriff (PDF)

Remarks on the Position Paper on Cardio-Onco-Hematology and Remarks on the Review of Cardiac Imaging Modalities for the Detection of Cardiotoxicity. Response

Revista española de cardiología (English ed.), 2017-11, Vol.70 (11), p.1029-1030

2017

Volltextzugriff (PDF)

Exercise intolerance among survivors of childhood cancer exposed to cardiotoxic therapy: Identification of survivors at increased risk through myocardial strain and ejection fraction

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.10565-10565

2018

Volltextzugriff (PDF)

Puntualizaciones al documento de consenso en cardio-onco-hematología y a la revisión sobre técnicas de imagen cardiaca en detección de cardiotoxicidad. Respuesta

Revista española de cardiologia, 2017-11, Vol.70 (11), p.1029-1030

2017

Volltextzugriff (PDF)

Impact of physician's perception about LDL cholesterol control in clinical practice when treating patients in Spain

Atherosclerosis, 2023-06, Vol.375, p.38-44

2023

Volltextzugriff (PDF)

The HIV/AIDS Vaccine Candidate MVA-B Administered as a Single Immunogen in Humans Triggers Robust, Polyfunctional, and Selective Effector Memory T Cell Responses to HIV-1 Antigens

Journal of Virology, 2011-11, Vol.85 (21), p.11468-11478

2011

Volltextzugriff (PDF)

Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

Clinical microbiology and infection, 2020-11, Vol.26 (11), p.1525-1536

2020

Volltextzugriff (PDF)

Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization

PloS one, 2017-10, Vol.12 (10), p.e0186602-e0186602

2017

Volltextzugriff (PDF)

Hypercholesterolaemia control in Spain: The same situation with different regional realities

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis, 2023-09, Vol.35 (5), p.219-225

2023

Volltextzugriff (PDF)

Determinants and Trends of the Use of Intravenous Thrombolysis for Minor Stroke: A Population-Based Study, 2016 to 2020

Stroke (1970), 2022-11, Vol.53 (11), p.3289-3294

2022

Volltextzugriff (PDF)

Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization

PloS one, 2018-04, Vol.13 (4), p.e0195915-e0195915

2018

Volltextzugriff (PDF)

Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1

Journal of antimicrobial chemotherapy, 2015-06, Vol.70 (6), p.1833-1842

2015

Volltextzugriff (PDF)

Setting priorities for an agenda within the Spanish pediatric emergency medicine research network

European journal of pediatrics, 2023-08, Vol.182 (8), p.3549-3558

2023

Volltextzugriff (PDF)

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pot and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)

Vaccine, 2011-10, Vol.29 (46), p.8309

2011

Volltextzugriff (PDF)

Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B

Vaccines (Basel), 2019-11, Vol.7 (4), p.178

2019

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(52)

Sprache

Englisch
(45)
Spanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hemodynamic outcomes after valve-in-valve transcatheter aortic valve replacement: a single-center experience

The cancer patient and cardiology

Patient Characteristics and Outcomes of Type 2 Myocardial Infarction During Heart Failure Hospitalizations in the United States

Contemporary impacts of a cancer diagnosis on survival following in-hospital cardiac arrest

Associations between global longitudinal strain (GLS), N-terminal-prohormone brain natriuretic peptide (NT-proBNP) and subsequent cardiomyopathy (CM) in a clinically assessed cohort of childhood cancer survivors exposed to cardiotoxic therapy

Transcatheter aortic valve replacement after chest radiation: A propensity-matched analysis

Remarks on the Position Paper on Cardio-Onco-Hematology and Remarks on the Review of Cardiac Imaging Modalities for the Detection of Cardiotoxicity. Response

Exercise intolerance among survivors of childhood cancer exposed to cardiotoxic therapy: Identification of survivors at increased risk through myocardial strain and ejection fraction

Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations

Puntualizaciones al documento de consenso en cardio-onco-hematología y a la revisión sobre técnicas de imagen cardiaca en detección de cardiotoxicidad. Respuesta

Cardio-Onco-Hematología en la práctica clínica. Documento de consenso y recomendaciones

Impact of physician's perception about LDL cholesterol control in clinical practice when treating patients in Spain

The HIV/AIDS Vaccine Candidate MVA-B Administered as a Single Immunogen in Humans Triggers Robust, Polyfunctional, and Selective Effector Memory T Cell Responses to HIV-1 Antigens

Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)

Hypercholesterolaemia control in Spain: The same situation with different regional realities

Determinants and Trends of the Use of Intravenous Thrombolysis for Minor Stroke: A Population-Based Study, 2016 to 2020

Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization

Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1

Setting priorities for an agenda within the Spanish pediatric emergency medicine research network

Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium

Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pot and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)

Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B

Suchergebnisse filtern